Published in Hepatology on February 01, 2009
Roles of liver innate immune cells in nonalcoholic fatty liver disease. World J Gastroenterol (2010) 1.05
Liver macrophages in healthy and diseased liver. Pflugers Arch (2017) 0.75
Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology (2007) 3.18
Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. J Hepatol (2009) 2.30
Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology (2006) 2.26
Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology (2005) 2.02
Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis. Gastroenterology (2009) 1.84
Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat Struct Mol Biol (2005) 1.83
Steatosis: co-factor in other liver diseases. Hepatology (2005) 1.76
Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging (2008) 1.56
Patched1 inhibits epidermal progenitor cell expansion and basal cell carcinoma formation by limiting Igfbp2 activity. Cancer Prev Res (Phila) (2010) 1.55
The growth hormone receptor: mechanism of activation and clinical implications. Nat Rev Endocrinol (2010) 1.44
In vivo analysis of growth hormone receptor signaling domains and their associated transcripts. Mol Cell Biol (2005) 1.31
In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. J Hepatol (2003) 1.29
GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism. Endocrinology (2010) 1.25
Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Hepatology (2004) 1.25
Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology (2005) 1.17
Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. J Hepatol (2003) 1.13
Exercise increases neural stem cell number in a growth hormone-dependent manner, augmenting the regenerative response in aged mice. Stem Cells (2009) 1.07
Obesity management in liver clinics: translation of research into clinical practice. J Gastroenterol Hepatol (2007) 1.07
Steatosis in chronic hepatitis C: association with increased messenger RNA expression of collagen I, tumor necrosis factor-alpha and cytochrome P450 2E1. J Gastroenterol Hepatol (2003) 1.05
How growth hormone controls growth, obesity and sexual dimorphism. Trends Genet (2007) 1.04
Constitutively active signal transducer and activator of transcription 5 can replace the requirement for growth hormone in adipogenesis of 3T3-F442A preadipocytes. Mol Endocrinol (2003) 1.04
SOCS3 as a tumor suppressor in breast cancer cells, and its regulation by PRL. Int J Cancer (2009) 1.00
Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis. Proc Natl Acad Sci U S A (2007) 1.00
In vivo targeting of the growth hormone receptor (GHR) Box1 sequence demonstrates that the GHR does not signal exclusively through JAK2. Mol Endocrinol (2009) 0.98
An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway. Nat Cell Biol (2008) 0.97
Investigating potential mechanisms of obesity by metabolomics. J Biomed Biotechnol (2012) 0.95
Altered metabolism of growth hormone receptor mutant mice: a combined NMR metabonomics and microarray study. PLoS One (2008) 0.95
Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis. Hepatology (2011) 0.95
Growth hormone receptor; mechanism of action. Int J Biochem Cell Biol (2007) 0.93
Characterization of the SOCS3 promoter response to prostaglandin E2 in T47D cells. Mol Endocrinol (2007) 0.93
Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis. J Hepatol (2008) 0.92
Comparative analysis of CNS populations in knockout mice with altered growth hormone responsiveness. Eur J Neurosci (2004) 0.92
The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis. Liver Int (2012) 0.92
Prolonged retention after aggregation into secretory granules of human R183H-growth hormone (GH), a mutant that causes autosomal dominant GH deficiency type II. Endocrinology (2002) 0.90
Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells. Mol Endocrinol (2007) 0.89
Virus-specific CD8+ T lymphocytes within the normal human liver. Eur J Immunol (2004) 0.89
Epitope map for a growth hormone receptor agonist monoclonal antibody, MAb 263. Mol Endocrinol (2003) 0.87
A conformationally sensitive GHR [growth hormone (GH) receptor] antibody: impact on GH signaling and GHR proteolysis. Mol Endocrinol (2004) 0.87
Dangerous liaisons: the metabolic syndrome and nonalcoholic fatty liver disease. Ann Intern Med (2005) 0.87
Caveolin-1 is necessary for hepatic oxidative lipid metabolism: evidence for crosstalk between caveolin-1 and bile acid signaling. Cell Rep (2013) 0.86
Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases. Dig Dis (2010) 0.86
Portal, but not lobular, macrophages express matrix metalloproteinase-9: association with the ductular reaction and fibrosis in chronic hepatitis C. Liver Int (2012) 0.86
Hepatic progenitor cell-mediated regeneration and fibrosis: chicken or egg? Hepatology (2009) 0.86
Role of growth hormone receptor signaling in osteogenesis from murine bone marrow progenitor cells. Biochem Biophys Res Commun (2005) 0.86
Growth hormone responsive neural precursor cells reside within the adult mammalian brain. Sci Rep (2012) 0.84
Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others. Clin Liver Dis (2007) 0.84
The extracellular domain of the growth hormone receptor interacts with coactivator activator to promote cell proliferation. Mol Endocrinol (2008) 0.84
Association between apolipoprotein E epsilon4 and neuropsychiatric symptoms during interferon alpha treatment for chronic hepatitis C. Psychosomatics (2004) 0.83
Genes induced by growth hormone in a model of adipogenic differentiation. Mol Cell Endocrinol (2002) 0.83
Regulation of rapid signal transducer and activator of transcription-5 phosphorylation in the resting cells of the growth plate and in the liver by growth hormone and feeding. Endocrinology (2009) 0.82
Inhibitory GH receptor extracellular domain monoclonal antibodies: three-dimensional epitope mapping. Endocrinology (2011) 0.82
Lymphocyte apoptosis and cell replacement in human liver allografts. Transplantation (2002) 0.82
A novel bioassay for human somatogenic activity in serum samples supports the clinical reliability of immunoassays. Clin Endocrinol (Oxf) (2002) 0.82
Growth hormone receptor targeting to lipid rafts requires extracellular subdomain 2. Biochem Biophys Res Commun (2009) 0.81
Influence of growth hormone on the craniofacial complex of transgenic mice. Eur J Orthod (2005) 0.81
Differential regulation of suppressor of cytokine signaling-3 in the liver and adipose tissue of the sheep fetus in late gestation. Am J Physiol Regul Integr Comp Physiol (2005) 0.81
Expression of functional recombinant human growth hormone in transgenic soybean seeds. Transgenic Res (2010) 0.80
Smg1 haploinsufficiency predisposes to tumor formation and inflammation. Proc Natl Acad Sci U S A (2012) 0.80
Increased site 1 affinity improves biopotency of porcine growth hormone. Evidence against diffusion dependent receptor dimerization. J Biol Chem (2004) 0.80
No evidence of the unfolded protein response in patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol (2011) 0.79
BMI but not stage or etiology of nonalcoholic liver disease affects the diagnostic utility of carbohydrate-deficient transferrin. Alcohol Clin Exp Res (2013) 0.79
Growth hormone and epidermal growth factor in salivary glands of giant and dwarf transgenic mice. J Histochem Cytochem (2004) 0.78
Influence of growth hormone on the mandibular condylar cartilage of rats. Arch Oral Biol (2004) 0.78
Heterozygote effects in mice with partial truncations in the growth hormone receptor cytoplasmic domain: assessment of growth parameters and phenotype. Endocrinology (2005) 0.78
Genetic disruption of the growth hormone receptor does not influence motoneuron survival in the developing mouse. Int J Dev Biol (2003) 0.78
Macrophage secretory products induce an inflammatory phenotype in hepatocytes. World J Gastroenterol (2012) 0.78
Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways. Liver Int (2013) 0.78
Activation of GH signaling and GH-independent stimulation of growth in zebrafish by introduction of a constitutively activated GHR construct. Transgenic Res (2010) 0.77
GH mediates exercise-dependent activation of SVZ neural precursor cells in aged mice. PLoS One (2012) 0.77
Not every cell is as it seems: a role for ductular epithelial cells in fibrosis? Gut (2010) 0.77
Maximal expression of suppressors of cytokine signaling in the rat ovary occurs in late pregnancy. Reproduction (2009) 0.77
Rewriting the mechanism of JAK2 activation. Cell Cycle (2015) 0.75
Caveolins in the repair phase of acute renal failure after oxidative stress. Nephrology (Carlton) (2004) 0.75
Crystallization and preliminary X-ray diffraction analysis of the unliganded human growth hormone receptor. Acta Crystallogr D Biol Crystallogr (2004) 0.75
Aerosolization of protein solutions using thermal inkjet technology. J Aerosol Med (2002) 0.75
Murine basal cell carcinoma leads to tumor-mediated alterations in endocrine Igf1 signaling. Endocr Relat Cancer (2013) 0.75